Piramal Pharma Limited has informed the Exchange about Transcript
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma has submitted to the stock exchanges the transcript of its conference call held on 29th July 2025, discussing the unaudited standalone and consolidated financial results for the quarter ended 30th June 2025. The transcript is now available on the company's website. No specific financial figures, guidance, or strategic commentary are disclosed in this filing — it is a routine regulatory submission under SEBI Listing Regulations. Investors can review the full transcript on the company's investor relations page for management's detailed commentary on Q1 performance.
No direct impact on the stock price from this filing alone, as it is a procedural disclosure. Investors seeking management commentary on margins, growth outlook, or strategy should review the actual conference call transcript on the company's website.